Evidence

A decade at the frontier of super-resolution imaging.

The methodology behind Magnephy was developed and validated over ten years of peer-reviewed research at KTH Royal Institute of Technology, SciLifeLab, and Karolinska Institutet.

Peer-reviewed

The foundational papers for our technology.

Customer story

Q32 Bio. Clinical-stage biotech in complement-mediated disease.

Q32 Bio applied Magnephy's platform across their preclinical program. Imaging at the nanoscale, in 3D and in intact tissue, gave the team answers that were out of reach before, and the confidence to move their program forward.

“
The results far exceeded even our most optimistic expectations, providing us with much deeper insight into the podocyte dynamics in our experiments. Moreover, the images Magnephy generated were breathtaking, providing a truly intuitive understanding of the underlying biology.
Preclinical and translational R&D team

Recognition

Magnephy in press.

Our technology has been featured in institutional news from SciLifeLab and Karolinska Institutet, and was selected for STING's 2024 deep-tech cohort.

SciLifeLab
Industry case · 2025
SciLifeLab features Magnephy's optical 3D microscopy and AI image analysis in its 2025 industry case.
Karolinska Institutet
News · 2025
Karolinska profiles Magnephy's work on 3D kidney diagnostics using advanced light microscopy and AI.
STING
Cohort · 2024
Selected for STING's 2024 health-tech and deep-tech accelerator cohort.

Tell us about your program. We reply within one business day.

Discuss a project →